AI-generated summary
The authors conducted a systematic review of 36 studies on photobiomodulation, which uses red or near-infrared light, in dementia, including in vitro, animal and patient work. They report that all included studies showed positive results and suggest larger clinical trials are warranted. The clinical studies were limited by small patient numbers, some lacked placebo controls, and few used objective neuroimaging.
- Studies included
- 36
- Who or what was studied
- Dementia patients, animal models of dementia, and in vitro studies (10 clinical, 17 animal, 9 in vitro)
- Limits stated in the abstract
- The clinical studies had small patient numbers, some lacked placebo controls, and only a few used objective neuroimaging methods.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dementia, Systematic review, Photobiomodulation therapy, Near-infrared, Irradiance, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.